Part I. Financial Information Condensed Financial Statements The SPAC reported $1.71 million net income for the nine months ended September 30, 2023, from Trust Account interest, with total assets of $73.2 million, facing going concern doubts due to a working capital deficit Condensed Balance Sheets As of September 30, 2023, total assets were $73.2 million, primarily in the Trust Account, with a $2.5 million shareholders' deficit due to redeemable share reclassification post-IPO Condensed Balance Sheet Data (Unaudited) | Account | September 30, 2023 | December 31, 2022 | | :--- | :--- | :--- | | Assets | | | | Cash | $56,540 | $0 | | Cash and investment held in Trust Account | $72,420,843 | $0 | | Total Assets | $73,232,853 | $592,570 | | Liabilities | | | | Total current liabilities | $879,746 | $577,372 | | Deferred underwriting commission | $2,415,000 | $0 | | Total Liabilities | $3,294,746 | $577,372 | | Equity | | | | Ordinary shares subject to possible redemption | $72,420,843 | $0 | | Total Shareholders' (Deficit)/Equity | ($2,482,736) | $15,198 | Condensed Statements of Operations Net income for the three and nine months ended September 30, 2023, was $486,555 and $1,712,827 respectively, solely from Trust Account interest offsetting operating costs Statement of Operations Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2023 | Nine Months Ended Sep 30, 2023 | | :--- | :--- | :--- | | Formation and operating costs | ($118,226) | ($466,016) | | Income earned on Trust Account | $604,781 | $2,178,843 | | Net Income | $486,555 | $1,712,827 | | Basic and diluted net income per share, redeemable | $0.07 | $0.54 | Condensed Statements of Changes in Shareholders' (Deficit)/Equity Shareholders' equity shifted from a $15,198 positive balance to a $2.48 million deficit by September 30, 2023, primarily due to IPO-related reclassification of redeemable shares - The company's equity shifted from a positive $15,198 at the end of 2022 to a deficit of ($2,482,736) by September 30, 202313 - Major changes in 2023 include the issuance of ordinary shares from the public offering ($69 million), private placements ($4.09 million), and the subsequent reclassification of $67.3 million in redeemable shares to temporary equity13 Condensed Statements of Cash Flows For the nine months ended September 30, 2023, financing activities provided $70.6 million, investing activities used $70.2 million for the Trust Account, resulting in a period-end cash balance of $56,540 Cash Flow Summary for Nine Months Ended Sep 30, 2023 (Unaudited) | Cash Flow Activity | Amount | | :--- | :--- | | Net cash used in operating activities | ($334,571) | | Net cash used in investing activities | ($70,242,000) | | Net cash provided by financing activities | $70,633,111 | | Net change in cash | $56,540 | | Cash at end of period | $56,540 | Notes to Unaudited Condensed Financial Statements The notes detail the company's SPAC formation, January 2023 IPO raising $69 million, a working capital deficit, and management's substantial doubt about its going concern ability, including sponsor loans - The company is a Cayman Islands incorporated blank check company formed to effect a business combination, with no operations to date, and all activities relate to its formation and IPO1718 - The company consummated its IPO on January 4, 2023, raising gross proceeds of $60 million, with an additional $9 million from an over-allotment option, and an aggregate of $70.24 million was placed in a Trust Account1921 - Management has concluded that the company's working capital deficit and need for additional capital raise substantial doubt about its ability to continue as a going concern3031 - On September 27, 2023, the sponsor provided a $690,000 non-interest-bearing loan to extend the business combination deadline from October 4, 2023, to January 4, 2024, convertible into ordinary shares upon a successful business combination7087 Management's Discussion and Analysis of Financial Condition and Results of Operations Management discusses the company's status as a blank check entity with no operations, its search for an Asian business combination target, and acknowledges substantial doubt about its going concern ability due to a working capital deficit - The company is a blank check company with no revenue, and its activities are limited to organizational tasks and preparing for a business combination8991 - The company intends to focus its search for a business combination on rapidly-growing targets in fintech, alternative energy, biotech, logistics, AI, and cloud industries, with a geographic focus on Asia90 - Management states that the company's financial condition, including a working capital deficit, raises substantial doubt about its ability to continue as a going concern100 Financial Results Summary | Period | Net Income | Key Driver | | :--- | :--- | :--- | | Q3 2023 | $486,555 | Income from Trust Account ($604,781) offset by operating costs ($118,226) | | Nine Months 2023 | $1,712,827 | Income from Trust Account ($2,178,843) offset by operating costs ($466,016) | Quantitative and Qualitative Disclosures About Market Risk As a smaller reporting company, detailed market risk disclosures are not required, but funds in the Trust Account are invested in short-term U.S. government securities with no material interest rate risk - As a smaller reporting company, the company is not required to provide detailed market risk disclosures126 - Funds in the Trust Account are invested in short-term U.S. government securities, and management believes there is no material exposure to interest rate risk101 Controls and Procedures As a newly public and emerging growth company, the assessment of internal controls over financial reporting is not yet complete, with no material changes reported this quarter - The company is not yet required to report on its internal controls under Section 404 of the Sarbanes-Oxley Act and has not completed an assessment127129 - There were no changes in internal control over financial reporting during the quarter that have materially affected, or are reasonably likely to materially affect, the company's internal controls130 Part II. Other Information Legal Proceedings No material litigation, arbitration, or other proceedings are currently pending against the company or its management team - To the knowledge of management, there are no pending material legal proceedings against the company131 Risk Factors No material changes to the risk factors previously disclosed in the Annual Report on Form 10-K filed on March 24, 2023, have occurred - No material changes to risk factors have occurred since the filing of the Form 10-K on March 24, 2023132 Unregistered Sales of Equity Securities and Use of Proceeds This section details unregistered equity sales, including 1,725,000 founder shares and 409,200 private placement units to the Sponsor, with $70.24 million net proceeds placed in the Trust Account - The Sponsor acquired a total of 1,725,000 founder shares133 - Simultaneously with the IPO and over-allotment, the company sold a total of 409,200 Private Placement Units to the Sponsor at $10.00 per unit, generating gross proceeds of $4,092,000134 - Net proceeds from the IPO and private placement totaling $70,242,000 were deposited into the Trust Account136 Other Information No other information was reported under this item - None136 Exhibits This section lists exhibits filed with the Form 10-Q, including officer certifications and Inline XBRL documents - Exhibits filed include Certifications of the Principal Executive Officer and Principal Financial Officer, as well as Inline XBRL data files138
AlphaTime Acquisition p(ATMC) - 2023 Q3 - Quarterly Report